OCUMENSION THERAPEUTICS revenue for the last year amounted to 34.70 M USD, the most of which — 34.85 M USD — came from its highest performing source at the moment, Ophthalmic Pharmaceutical Platform, the year earlier bringing 23.66 M USD. The greatest contribution to the revenue figure was made by China — last year it brought OCUMENSION THERAPEUTICS 34.85 M USD, and the year before that — 23.66 M USD.